Calliditas announces additions to the management team

"Jonathan has been instrumental in building up the US operations for Calliditas in every way and he will be sorely missed by all.  We wish him the very best.  We welcome Brian to the team and look forward to working with him as we embark on the next chapter of our journey," said Renée Aguiar-Lucander, CEO Calliditas. "Jonathan has been instrumental in building up the US operations for Calliditas in every way and he will be sorely missed by all.  We wish him the very best.  We welcome Brian to...

"Jonathan has been instrumental in building up the US operations for Calliditas in every way and he will be sorely missed by all.  We wish him the very best.  We welcome Brian to the team and look forward to working with him as we embark on the next chapter of our journey," said Renée Aguiar-Lucander, CEO Calliditas.

Lars Stubberud has more than 30 years' experience in the pharmaceutical industry within the broader CMC area, including Formulation Sciences, Product Development, Technology Transfer/Technical Stewardship as well as Regulatory Affairs- CMC and Quality Assurance. Prior to joining Calliditas in 2020, Lars has held various positions, including leadership roles, at Nyomed AS, AstraZeneca, as well as Cubist Pharmaceuticals GmbH, Biogen International GmbH and Alexion Pharma GmbH. Lars has a Master of Science (candidatus pharmaciae) and PhD in Pharmaceutical Science from the University of Oslo, Norway.

CONTACT:

For further information, please contact:
Åsa Hillsten, Head of IR & Sustainability, Calliditas
Tel.: +46 76 403 35 43, Email: asa.hillsten@calliditas.com

The information was sent for publication, through the agency of the contact persons set out above, on 1 December, 2023 at 09:00 a.m. CET.

The following files are available for download:

 

View original content:https://www.prnewswire.co.uk/news-releases/calliditas-announces-additions-to-the-management-team-302003070.html